Viking, CRISPR, Cytokinetics are M&A targets: Wells Fargo :

Viking, CRISPR, Cytokinetics are M&A targets: Wells Fargo

Viking, CRISPR, Cytokinetics are M&A targets: Wells Fargo

seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Moonlake Immunotherapeutics , Arcutis Biotherapeutics , Zealand Pharma , Verona Pharma , Bridgebio Pharma , Mohit Bansal , Neurocrine Biosciences , Iovance Biotherapeutics , Wells Fargo , Alnylam Pharmaceuticals , Rhythm Pharmaceuticals , Apellis Pharmaceuticals , Arrowhead Pharmaceuticals , Amicus Therapeutics , Xenon Pharmaceuticals , Madrigal Pharmaceuticals , Mirum Pharmaceuticals , Morphic Holding , Viking Therapeutics , Intellia Therapeutics , Bristol Myers , Point Biopharma , Eli Lilly , Intra Cellular Therapies , Revolution Medicines , Blueprint Medicines , Bio Pharma , Krystal Biotech , Axsome Therapeutics , Avidity Biosciences , Denali Therapeutics , Apogee Therapeutics , Beam Therapeutics , Bavarian Nordic , Edgewise Therapeutics , Harmony Biosciences , Arcus Biosciences , Day One Biopharmaceuticals , Cullinan Therapeutics , Nurix Therapeutics , Bicycle Therapeutics , New Jersey Based , Harpoon Therapeutics ,